0
0
12/29/22 at 1:24am
Organization
Reuters
59 words
0
Comments
Novartis AG <a href="https://www.reuters.com/companies/NOVN.S" target="_blank">(NOVN.S)</a> said on Wednesday it will pay $245 million to end antitrust litigation accusing the Swiss drugmaker of trying to delay the launch in the United States of generic versi…
You are the first to view
https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-pay-245-mln-over-exforge-drug-generics-2022-12-29/
Create an account
or login to join the discussion